Cargando…
Innovative Therapeutic Approaches for the Treatment of the Ocular Morbidities in Patients with EEC Syndrome
Ectrodactyly-Ectodermal dysplasia-Clefting (EEC) syndrome is caused by heterozygous missense point mutations in the p63 gene, an important transcription factor during embryogenesis and for stem cell differentiation in stratified epithelia. Most of the cases are sporadic, related to de novo mutations...
Autores principales: | Barbaro, Vanessa, Bonelli, Filippo, Ferrari, Stefano, La Vella, Giulia, Di Iorio, Enzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914602/ https://www.ncbi.nlm.nih.gov/pubmed/36766837 http://dx.doi.org/10.3390/cells12030495 |
Ejemplares similares
-
Reconstruction of a human hemicornea through natural scaffolds compatible with the growth of corneal epithelial stem cells and stromal keratocytes
por: Barbaro, Vanessa, et al.
Publicado: (2009) -
Ocular Manifestations of Ectrodactyly-Ectodermal Dysplasia-Cleft Palate (EEC) Syndrome: A Case Report
por: Mohd Jais, Mohammad Fahim, et al.
Publicado: (2023) -
Retinitis Pigmentosa: Genes and Disease Mechanisms
por: Ferrari, Stefano, et al.
Publicado: (2011) -
Analysis and pharmacological modulation of senescence in human epithelial stem cells
por: Barbaro, Vanessa, et al.
Publicado: (2022) -
Memorandum to the Chairman of the EEC
por: Stierlin, U, et al.
Publicado: (1968)